See also
this year's filing and
all EDGAR filings for this company.
PDF Report 0000810509_2013_Navidea_Biopharmaceuticals_Inc.pdf
Logs
| warning |
The stock price does not exist |
industry.us_generic |
{} |
| info |
Failed to set obs_EconomicCapitalRatio |
industry.us_generic |
{'reason': "KeyError('0000810509')"} |
Graph
Absolute values for 0000810509, Navidea Biopharmaceuticals Inc
| |
xvar |
xval |
| 0 |
LiabilitiesNoncurrent |
257,122 |
| 1 |
LiabilitiesCurrent |
6,190,539 |
| 2 |
remainder_Liabilities |
6,930,112 |
| 3 |
AssetsCurrent |
10,617,383 |
| 4 |
AssetsNoncurrent |
327,954 |
| 5 |
PropertyPlantAndEquipmentNet |
934,578 |
| 6 |
Goodwill |
92,482 |
| 7 |
remainder_Assets |
0 |
| 8 |
GeneralAndAdministrativeExpense |
11,177,559 |
| 9 |
ResearchAndDevelopmentExpense |
16,890,482 |
| 10 |
remainder_Expenses |
0 |
| 11 |
remainder_Revenues |
78,738 |
| 12 |
remainder_NetIncome |
-1,167,901 |
| 13 |
remainder_ComprehensiveNetIncome |
0 |
| |
yvar |
yval |
| 0 |
Liabilities |
13,377,773 |
| 1 |
Assets |
11,972,397 |
| 2 |
Expenses |
28,068,041 |
| 3 |
Revenues |
78,738 |
| 4 |
StockholdersEquity |
-1,405,376 |
| 5 |
NetIncome |
-29,157,204 |
| 6 |
ComprehensiveNetIncome |
-29,157,204 |
| 7 |
BaseVar |
27,332,425 |
| 8 |
EconomicCapitalRatiobeforeLimitedLiability |
-2.45 |
| 9 |
EconomicCapitalRatio |
0.222 |
Edgar->Model Mapping
Feature Distribution
Change over Time
